Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Deferred Taxes came in at -$204000.0 in Q1 2026, up 56.87% YoY from -$130043.1 in Q1 2025, and up 94.73% on a QoQ basis from -$3.9 million in Q4 2025.
Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Deferred Taxes data on file, last reported at -$204000.0 in Q1 2026.
- Quarterly Deferred Taxes rose 56.87% year-over-year to -$204000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 184.35% YoY) and the FY2025 annual result came in at -$3.7 million, down 1898.06% from the prior year.
- Deferred Taxes advanced to -$204000.0 in Q1 2026, from -$3.9 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $4.4 million in Q4 2022 to a low of -$24.9 million in Q3 2023.
- A 5-year average of -$2.4 million and a median of -$473000.0 in 2025 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes slumped 374.52% — and 2024, when it surged 817.18%.
- Tracing CRLBF's Deferred Taxes over 5 years: stood at $4.4 million in 2022, then sank by 261.68% to -$7.1 million in 2023, then jumped by 54.42% to -$3.2 million in 2024, then dropped by 19.16% to -$3.9 million in 2025, then surged by 94.73% to -$204000.0 in 2026.
- The last three Deferred Taxes figures came in at -$204000.0 (Q1 2026), -$3.9 million (Q4 2025), and $305000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn | -29.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -204,000.00 |
| Dec 31, 2025 | -3.87 Mn |
| Sep 30, 2025 | 305,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | -473,000.00 |
| Dec 31, 2024 | -3.25 Mn |
| Sep 30, 2024 | -479,000.00 |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 941,000.00 |
| Dec 31, 2023 | -7.12 Mn |
| Sep 30, 2023 | -24.88 Mn |
| Jun 30, 2023 | 326,000.00 |
| Mar 31, 2023 | -987,000.00 |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | -7.17 Mn |
| Jun 30, 2022 | -1.68 Mn |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | -28.35 Mn |
| Jun 30, 2021 | -8.73 Mn |